Marginal Zone Lymphoma — Trials

Marginal Zone Lymphoma — Trials · CancerIndex

Clinical trials

Registered studies

407 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 111
Recruiting: 62
Ph III recruiting: 2
Growth YoY: —
Industry share: 22%
Top sponsor: City of Hope Medical Center
Termination share: 38.9%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (79)

clinicaltrialsPublishedShowing 1–2 of 2 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT06006117	Mosunetuzumab-Lenalidomide Versus Investigator Choices in Patients With Relapsed or Refractory Marginal Zone Lymphoma	recruiting	Phase 3	260	The Lymphoma Academic Research OrganisationOTHER	5	Jun 15, 2026	clinicaltrials
NCT07029217	A Study of Reduced Dose Radiation Therapy for People With B-Cell Lymphomas	recruiting	Phase 3	375	Memorial Sloan Kettering Cancer CenterOTHER	1	Feb 17, 2026	clinicaltrials